Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy Bank of America Co.

Galmed Pharmaceuticals Ltd.
Start price
€6.40
07.11.25 / 50%
Target price
€78.87
07.11.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 07.11.26. The prediction end date can be changed by Bank_of_America_Co_ at any time.
Performance without dividends (%)
Name 1w 1m
Galmed Pharmaceuticals Ltd. - -
iShares Core DAX® 3,59 % 3,93 %
iShares Nasdaq 100 5,81 % 5,52 %
iShares Nikkei 225® 4,08 % 8,46 %
iShares S&P 500 4,14 % 4,04 %

Comments by Bank_of_America_Co_ for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) -
Target price 78.870
Change
Ends at 07.11.26

Globus Medical (NYSE:GMED) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $91.00 price target on the stock, up previously from $65.00.
Ratings data for GMED provided by MarketBeat

Bank of America Co. 
0
Report Share
07.11.25

Stopped prediction by Bank_of_America_Co_ for Galmed Pharmaceuticals Ltd.

sell
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
06.11.24
€74.68
06.11.25
-
07.11.25

Bank of America Co. 
06.11.24 50%